Caption Management, LLC Acadia Pharmaceuticals Inc Transaction History

Caption Management, LLC

$8.03 Billion
Q2 2025

A detailed history of Caption Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Caption Management, LLC holds 30,000 shares of ACAD stock, worth $641,400. This represents 0.01% of its overall portfolio holdings.

Number of Shares

30,000

Previous 20,000 50.0%

Holding current value

$641,400

Previous $332,000 94.88%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$14.1 - $22.95 $800,442 - $1.3 Million	-56,769 Reduced 87.04%	8,455 $182,000
Q1 2025 May 15, 2025	BUY	$16.61 - $20.29 $1.08 Million - $1.32 Million	65,224 New	65,224 $1.08 Million
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $859,656 - $1.08 Million	-58,800 Reduced 88.29%	7,800 $126,000
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $1.18 Million - $2.06 Million	66,600 New	66,600 $1.23 Million
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $221,612 - $463,665	-17,034 Reduced 90.61%	1,766 $25,000
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $56,538 - $74,250	-2,700 Reduced 12.56%	18,800 $455,000
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $560,190 - $879,335	-35,500 Reduced 62.28%	21,500 $357,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $1.06 Million - $1.5 Million	-54,700 Reduced 48.97%	57,000 $1.39 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $1.28 Million - $2.81 Million	51,100 Added 84.32%	111,700 $2.88 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $1.05 Million - $1.45 Million	25,600 Added 73.14%	60,600 $3.24 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $562,943 - $881,049	-15,457 Reduced 30.63%	35,000 $1.44 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $1.98 Million - $2.66 Million	50,457 New	50,457 $2.45 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $655,155 - $970,209	-20,700 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$36.21 - $51.4 $155,703 - $221,020	-4,300 Reduced 17.2%	20,700 $885,000
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $555,500 - $1.1 Million	25,000 New	25,000 $899,000
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $469,080 - $785,160	-36,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $542,520 - $804,240	36,000 New	36,000 $549,000

Others Institutions Holding ACAD

# of Institutions

346

Shares Held

165M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.46B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account

Caption Management, LLC Acadia Pharmaceuticals Inc Transaction History